Alligator Bioscience AB Stock
Stocks
ATORX
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 0.0230 SEK | -4.17% |
|
-10.51% | -93.17% |
| 09-07 | Alerts on Alligator Bioscience conducting rights issue withdrawn | RE |
| 09-01 | Alligator Bioscience shares trade today on Nasdaq Stockholm ex-rights for units in rights issue | FW |
| Market Cap | 14.45M 1.49M 1.29M 1.21M 1.11M 2.07M 143M 2.08M 5.56M 72.49M 5.61M 5.49M 230M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 14.45M 1.49M 1.29M 1.21M 1.11M 2.07M 143M 2.08M 5.56M 72.49M 5.61M 5.49M 230M | EV / Sales 2026 * |
2.45x | EV / Sales 2027 * | 0.29x |
| Free-Float |
83.58% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ATORX | Delayed | |
CBOE
| ATORXs | Real-time | |
|
OTC Markets
| ALLGF | Delayed | |
|
Deutsche Boerse AG
| 7AL0 | Delayed | |
|
CBOE
| 0RK9 | Real-time | |
|
Börse Stuttgart
| 7AL0 | Delayed |
Last Transcript : Alligator Bioscience AB
| 1 day | -4.17% | ||
| 1 week | -10.51% | ||
| Current month | -25.57% | ||
| 1 month | -39.47% | ||
| 3 months | -87.98% | ||
| 6 months | -88.92% | ||
| Current year | -93.17% |
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.49 |
| 1 year | 0.02 | | 5.6 |
| 3 years | 0.02 | | 1,568 |
| 5 years | 0.02 | | 4,695 |
| 10 years | 0.02 | | 40,100 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 2021-05-31 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 2024-08-11 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 2021-05-31 | |
Denise Goode
BRD | Director/Board Member | 68 | 2022-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/5/25 | Buy | Chairman | 800,000 | 0.0047% | ||
| 3/5/25 | Buy | Chairman | 77,319 | 0.0005% | ||
| 3/5/25 | Sell | Chairman | 1,658,134 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.17% | -10.51% | -99.39% | -99.99% | 1.57M | |
| -0.56% | -8.08% | -3.88% | +9.81% | 46.38B | |
| -2.14% | -3.84% | +401.27% | +516.87% | 44.51B | |
| +0.17% | -5.40% | +39.74% | +19.32% | 42.3B | |
| -2.38% | -4.86% | +9.91% | +64.90% | 39.91B | |
| -1.26% | -2.95% | +12.00% | +40.55% | 32.79B | |
| -0.31% | -4.16% | - | - | 17.13B | |
| -0.63% | -1.64% | +22.44% | +108.93% | 16.36B | |
| -0.03% | -3.46% | +12.68% | +30.90% | 14.31B | |
| -2.17% | -7.16% | +77.69% | +36.41% | 13.29B | |
| Average | -1.32% | -3.68% | +52.50% | +80.85% | 26.7B | |
| Weighted average by Cap. | -1.08% | -3.25% | +86.98% | +123.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 611K 525K 495K 451K 844K 58.37M 851K 2.27M 29.61M 2.29M 2.24M 94.04M | 49.7M 5.14M 4.42M 4.17M 3.8M 7.11M 492M 7.17M 19.13M 249M 19.31M 18.89M 792M |
| Net income | -15.2M -1.57M -1.35M -1.28M -1.16M -2.17M -150M -2.19M -5.85M -76.27M -5.91M -5.78M -242M | 28.9M 2.99M 2.57M 2.43M 2.21M 4.13M 286M 4.17M 11.12M 145M 11.23M 10.98M 461M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | SEK 0.0230 | -4.17% | 4,060,089 |
| 26-09-09 | SEK 0.0240 | 0.00% | 16,793,301 |
| 26-09-08 | SEK 0.0240 | -7.69% | 12,644,828 |
| 26-09-07 | SEK 0.0260 | +4.00% | 22,424,924 |
| 26-09-04 | SEK 0.0250 | -2.72% | 24,731,673 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
Select your edition
All financial news and data tailored to specific country editions
